Leap Therapeutics Inc - Company Profile
Powered by 
All the data and insights you need on Leap Therapeutics Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date Leap Therapeutics Inc Strategy Report
- Understand Leap Therapeutics Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Business Description
Leap Therapeutics Inc (Leap Therapeutics) is an early-stage biopharmaceutical company that acquires and develops novel therapeutics for the treatment of cancer.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
R&D Overview
The company's R&D efforts focus on advancing its nonclinical studies and clinical trials of its pipeline candidates. The company spent US$45 million on its R&D activities in FY2022, which grew 39.8% YoY. As of December 31, 2022, the company had 33 employees working in research and development activities.
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer